C12N 2750/14142
Virus or viral particle as vehicle
Official title: virus or viral particle as vehicle, e.g. encapsulating small organic molecule
C12N2750/14142 (Virus or viral particle as vehicle) appears on 133 US grants and 270 published applications in this corpus.
Search patents in C12N- Granted patents
- 133
- Published applications
- 270
- Assignees
- 111
- Inventors
- 336
- Latest grant
- 22 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2001 | 1 | 0 |
| 2002 | 0 | 1 |
| 2003 | 0 | 1 |
| 2004 | 0 | 1 |
| 2005 | 1 | 1 |
| 2006 | 0 | 0 |
| 2007 | 0 | 2 |
| 2008 | 0 | 1 |
| 2009 | 1 | 4 |
| 2010 | 0 | 4 |
| 2011 | 2 | 1 |
| 2012 | 2 | 2 |
| 2013 | 1 | 5 |
| 2014 | 3 | 10 |
| 2015 | 3 | 14 |
| 2016 | 5 | 13 |
| 2017 | 9 | 16 |
| 2018 | 9 | 15 |
| 2019 | 9 | 13 |
| 2020 | 7 | 22 |
| 2021 | 12 | 22 |
| 2022 | 13 | 51 |
| 2023 | 10 | 27 |
| 2024 | 13 | 22 |
| 2025 | 13 | 11 |
| 2026 | 19 | 11 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Methods of treating rheumatoid arthritis using RNA-guided genome editing of HLA gene22 Sep 2026US 12,742,179 B2National Jewish Health
- Effective dosages of an adenoviral-based biological delivery and expression system for use in the treatment of osteoarthritis in humans, and compositions comprising the same25 Aug 2026US 12,714,755 B2Pacira Therapeutics, Inc.
- Artificial expression constructs for selectively modulating gene expression in selected neuronal cell populations11 Aug 2026US 12,702,722 B2Allen Insitute
- Engineered muscle targeting compositions30 Jun 2026US 12,668,814 B2Massachusetts Institute of Technology
- Targeting peptides for directing adeno-associated viruses (AAVs)16 Jun 2026US 12,653,904 B2California Institute of Technology
- Primate carbonic anhydrase iv binding peptides and aavs1 Oct 2026US 2026/0294834 A1California lnstitute of Technology
- Dual aav vectors for treating stargardt disease1 Oct 2026US 2026/0295092 A1Atsena Therapeutics, Inc.
- Oligonucleotides for htt-1a modulation10 Sep 2026US 2026/0265747 A1University of Massachusetts
- Engineered muscle targeting compositions27 Aug 2026US 2026/0250713 A1Massachusetts Institute of Technology
- Novel aav capsids and compositions containing same20 Aug 2026US 2026/0242825 A1The Trustees of the University of Pennsylvania
Most cited
By later US patents
- Adeno-associated virus (AAV) clades, sequences, vectors containing same, and uses therefor346US 7,906,111 B2The Trustees of the University of Pennsylvania · 2011
- Induction of exon skipping in eukaryotic cells154US 7,973,015 B2Academisch Ziekenhuis Leiden · 2011
- Methods of treating Parkinson's disease using recombinant adeno-associated vector (rAAV)108US 6,309,634 B1Avigen, Inc. · 2001
- Method of increasing the function of an AAV vector70US 8,999,678 B2The Trustees of the University of Pennsylvania · 2015
- Adeno-associated virus virions with variant capsid and methods of use thereof68US 9,458,517 B2The Regents of the University of California · 2016